Abstract:The ligand 2-['2-(4,5-dimethyl thiazolyl)azo]-imidazole (DMeTAI), which is generated from 2-amino-4,5-dimethylthiazol and imidazole, was used to synthesize coordination compounds containing Ni(II) and Cu(II) ions. To confirm the structure of the synthesized chelates, a range of analytical techniques were used, including thermal analysis, X-ray powder diffraction, infrared spectroscopy, mass spectrometry, magnetic susceptibility analysis, microanalysis, and 1 H NMR. The complexes have the formula [M(L) 2 ]Cl 2 .H 2 O, where M stands for Ni(II) or Cu(II), and the results showed that the metal ion–ligand ratio was 1:2. Molar conductivity results demonstrated that the complexes are all electrolytes that fall within a certain range 77.01–83.56 Ω −1 cm 2 mol −1 , and the magnetic susceptibility measurements indicated an octahedral structural geometry for the complexes. Besides, the central metal ion interacts with the ligand as a tridentate (N,N,N) coordination by the (C=N) nitrogen atom from the thiazole moiety, the (N=N) nitrogen atom from the azo group, and the (C=N) nitrogen atom from the imidazole moiety. Thermal analysis (TG/DTG) showed that the thermal decomposition of the obtained compounds is a multi-stage process depending on the metal ion and atmosphere in which was conducted. Computational methods were subsequently utilized to delve more deeply into the properties of both the ligand and metallic complexes. The structural formulas of the examined azo dye ligand and metal complexes were optimized using the Gaussian09 program. Additionally, the DFT/B3LYP method was employed to compute energy gaps and other pertinent theoretical parameters. Molecular docking using the MOE 2015 program was utilized to explore the interactions of the compounds with the human p110alpha/p85alpha complex (PDB ID: 2RD0), which is associated with ovarian carcinoma. We determined the energies of hydrophobic and hydrogen bonding from the analysis of the docked protein receptors. In addition to the theoretical investigations, both the ligand and metallic complexes were evaluated for their effectiveness as antibacterial agents against Staphylococcus aureus (Gram-positive), Escherichia coli (Gram-negative), and the antifungal strain Penicillium sp. The findings revealed that the ligand and its metallic complexes demonstrated moderate antimicrobial efficacy against both Gram-positive and Gram-negative microbes, surpassing the standard drugs Ciprofloxacin and Cycloheximide. Additionally, the cytotoxicity of the ligand was assessed against human ovarian carcinoma cancer cells (SKOV-3). Furthermore, in silico ADMET analysis predicted favourable pharmacokinetic and toxicity profiles for the synthesized molecules, indicating promising oral drug-like properties and a nontoxic nature.

Synthesis, Characterization, Antimicrobial, DNA Cleavage and Fluorescent Activity of Metal ion(II) Coordinate with 2H-Chromene Azo novel ligand

Synthesis, and characterization of Ni(II), and Cu(II) metal complexes containing new azo dye ligand (N,N,N) and evaluation of their biological activities supported by DFT studies, molecular docking, ADMET profiling, drug-likeness analysis and toxicity prediction

Synthesis, characterization and antioxidant, antibacterial activity Zn2+, Cu2+, Ni2+ and Co2+, complexes of ligand [2-(thiophen-2-yl)-1-(thiophen-2-ylmethyl)-1H-benzo[d]imidazole]

Synthesis and characterization of novel metal complexes with new azo-schiff base ligand derived from sulfa drug and toxicological studies of its complexes as antibacterial

Synthesis, Characterization, DNA Cleavage, and Antimicrobial Studies of Some Transition Metal Complexes With a Novel Schiff Base Derived From 2-Aminopyrimidine

Synthesis, Characterization, DFT and Antibacterial, Azo Ligand Derived From 2-Amino pyrimidine With Antipyrine Mixed ligand Complexes involving 1,10- phenanthroline

Crystal structures, electronic spectra and anticancer properties of new azo-azomethines and their nickel(II) and copper(II) chelates

Preparation, Characterization, Antioxidant and Antibacterial Studies of New Metal (II) Complexes with Schiff Base for 3-amino-1-phenyl-2- pyrazoline-5-one

Analyzing the structure of the metal complexes of biologically active azo dye ligand

New Cu (II) and Zn (II) metal chelates derived from azo‐Schiff bases: Synthesis, DNA/BSA binding, anticancer activity and molecular docking studies

Synthesis, Structural Characterization, in Vitro Biological Activity, and Computational Quantum Chemical Studies of New Cobalt (II), Nickel (II), and Copper (II) Complexes Based on an Azo-Azomethine Ligand

Synthesis, spectro-themal characterization, DFT calculations and biochemical evaluation of a newly synthesized tridentate Schiff base transition metal complexes

Synthesis, Characterization and Biological Activity of Heterocyclic Azo-Schiff Base Ligand derived from 2-Amino-5-methyl thiazol and some Transition Metal Ions

Design, Synthesis, Structural Investigation and Photo Induced Biological Investigations of Co(II), Ni(II) and Cu(II) Complexes Derived from N,O Donor Schiff Bases

Synthesis, Characterization, Antimicrobial, Density Functional Theory, and Molecular Docking Studies of Novel Mn(II), Fe(III), and Cr(III) Complexes Incorporating 4-(2-Hydroxyphenyl azo)-1-naphthol (Az)

Synthesis, structural characterization, density functional theory, anticancer, and antimicrobic studies of Ni2+ and Cu2+ complexes encompassing tridentate ONS‐donor azo‐thiosemicarbazone

Novel 1,3‐diphenyl‐4‐(N,N‐dimethylimido dicarbonimidic diamide azo)‐5‐pyrazolone and its chelates with manganese, nickel, copper, and zinc divalent metal ions as an antibacterial activity supported by molecular docking studies: Design, synthesis, DFT, and TD‐DFT/PCM calculations

Synthesis, characterization, antimicrobial, molecular docking simulation, and antitumor assays of nanometric complexes based on new thiazole Schiff base derivative

Synthesis, structural characterization, in vitro biological activity, and DFT calculations of Cu(II) complex

Novel metal(II) complexes with pyrimidine derivative ligand: synthesis, multi-spectroscopic, DNA binding/cleavage, molecular docking with DNA/BSA, and antimicrobial studies

Azo naringenin‐based copper (II) complex as DNA binder: Synthesis, spectroscopic characterization, and diverse biological potentials